EYEG - アイゲ―ト・ファ―マシュ―ティカルズ (Eyegate Pharmaceuticals Inc.)

EYEGのニュース

   EyeGate is Now Kiora Pharmaceuticals; Provides Update on Companys Sharpened Clinical Development Strategy  2021/11/08 12:30:00 Intrado Digital Media
SALT LAKE CITY, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), (Kiora or the Company) is the new name of EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG). Kiora will trade on the Nasdaq Capital Market under the ticker symbol "KPRX" and CUSIP number 49721T101. The new brand reflects the Companys aim to not only treat common eye conditions, but to develop a revolutionary small molecule therapy that has the potential to restore vision loss for a rare, inherited degenerative retinal disease, Retinitis Pigmentosa. The Companys newly revamped clinical development strategy is available in the Investors section of the Companys new website at www.kiorapharma.com .
   EyeGate Pharmaceuticals Inc. (NASDAQ: EYEG) Offers Great Upside  2021/11/06 18:00:00 Stocks Register
EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) shares, rose in value on Friday, 11/05/21, with the stock price down by -1.52% to the previous days close as strong demand from buyers drove the stock to $1.95. Actively observing the price movement in the last trading, the stock closed the session at $1.98, falling within a range of $1.92 EyeGate Pharmaceuticals Inc. (NASDAQ: EYEG) Offers Great Upside Read More »
   EyeGate Pharmaceuticals Inc. (NASDAQ: EYEG) Could Slash -689.47% Soon  2021/10/30 18:00:00 Stocks Register
EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) price on Friday, October 29, rose 0.53% above its previous days close as an upside momentum from buyers pushed the stocks value to $1.90. A look at the stocks price movement, the close in the last trading session was $1.89, moving within a range at $1.86 and $1.935. The beta value EyeGate Pharmaceuticals Inc. (NASDAQ: EYEG) Could Slash -689.47% Soon Read More »
   Can EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) Stock Be A Good Mid-Term Investment?  2021/10/27 11:30:00 Stocks Register
EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) price closed higher on Tuesday, October 26, jumping 4.10% above its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy
   stocks Performances and Technicals to scrutinize: Northern Dynasty Minerals Ltd. (AMEX:NAK 0.46%), EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG 2.40%)  2021/10/22 00:17:21 Stock Equity
There are two main reasons why moving averages are useful in forex trading: Ø moving averages help traders define trend Ø recognize changes in trend. Now well have a look The post stocks Performances and Technicals to scrutinize: Northern Dynasty Minerals Ltd. (AMEX:NAK 0.46%), EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG 2.40%) appeared first on Stocks Equity .
   EyeGate is Now Kiora Pharmaceuticals; Provides Update on Companys Sharpened Clinical Development Strategy  2021/11/08 12:30:00 Intrado Digital Media
SALT LAKE CITY, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), (Kiora or the Company) is the new name of EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG). Kiora will trade on the Nasdaq Capital Market under the ticker symbol "KPRX" and CUSIP number 49721T101. The new brand reflects the Companys aim to not only treat common eye conditions, but to develop a revolutionary small molecule therapy that has the potential to restore vision loss for a rare, inherited degenerative retinal disease, Retinitis Pigmentosa. The Companys newly revamped clinical development strategy is available in the Investors section of the Companys new website at www.kiorapharma.com .
   EyeGate Pharmaceuticals Inc. (NASDAQ: EYEG) Offers Great Upside  2021/11/06 18:00:00 Stocks Register
EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) shares, rose in value on Friday, 11/05/21, with the stock price down by -1.52% to the previous days close as strong demand from buyers drove the stock to $1.95. Actively observing the price movement in the last trading, the stock closed the session at $1.98, falling within a range of $1.92 EyeGate Pharmaceuticals Inc. (NASDAQ: EYEG) Offers Great Upside Read More »
   EyeGate Pharmaceuticals Inc. (NASDAQ: EYEG) Could Slash -689.47% Soon  2021/10/30 18:00:00 Stocks Register
EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) price on Friday, October 29, rose 0.53% above its previous days close as an upside momentum from buyers pushed the stocks value to $1.90. A look at the stocks price movement, the close in the last trading session was $1.89, moving within a range at $1.86 and $1.935. The beta value EyeGate Pharmaceuticals Inc. (NASDAQ: EYEG) Could Slash -689.47% Soon Read More »
   Can EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) Stock Be A Good Mid-Term Investment?  2021/10/27 11:30:00 Stocks Register
EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) price closed higher on Tuesday, October 26, jumping 4.10% above its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy
   stocks Performances and Technicals to scrutinize: Northern Dynasty Minerals Ltd. (AMEX:NAK 0.46%), EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG 2.40%)  2021/10/22 00:17:21 Stock Equity
There are two main reasons why moving averages are useful in forex trading: Ø moving averages help traders define trend Ø recognize changes in trend. Now well have a look The post stocks Performances and Technicals to scrutinize: Northern Dynasty Minerals Ltd. (AMEX:NAK 0.46%), EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG 2.40%) appeared first on Stocks Equity .
   Where Do Hedge Funds Stand On Eyegate Pharmaceuticals, Inc. (EYEG)?  2021/06/30 13:56:26 Insider Monkey
   Eyegate Pharmaceuticals reports Q1 results  2021/05/12 20:44:04 Seeking Alpha
   EyeGate Pharma Reports First Quarter 2021 Financial Results and Provides Business Update  2021/05/12 20:15:00 GlobeNewswire
- PP-001: proof-of-concept study in Austria for dry eye patients expected to initiate in Q3:21; U.S. IND submission planned in Q4:21-
   Analysts Are Pretty Bullish EyeGate Pharmaceuticals (NASDAQ:EYEG)  2021/05/12 10:07:00 Stock Market Daily
Earnings results for EyeGate Pharmaceuticals , Analyst Opinion on EyeGate Pharmaceuticals , Earnings and Valuation of (NASDAQ:EYEG), Stock market Insights & financial analysis, Best stock to invest, Investment Idea, The post Analysts Are Pretty Bullish EyeGate Pharmaceuticals (NASDAQ:EYEG) appeared first on .

calendar